120 related articles for article (PubMed ID: 7631774)
1. A limitation in the use of mass isotopomer distributions to measure gluconeogenesis in fasting humans.
Landau BR; Fernandez CA; Previs SF; Ekberg K; Chandramouli V; Wahren J; Kalhan SC; Brunengraber H
Am J Physiol; 1995 Jul; 269(1 Pt 1):E18-26. PubMed ID: 7631774
[TBL] [Abstract][Full Text] [Related]
2. Gluconeogenesis and glucuronidation in liver in vivo and the heterogeneity of hepatocyte function.
Ekberg K; Chandramouli V; Kumaran K; Schumann WC; Wahren J; Landau BR
J Biol Chem; 1995 Sep; 270(37):21715-7. PubMed ID: 7665589
[TBL] [Abstract][Full Text] [Related]
3. Limitations of the mass isotopomer distribution analysis of glucose to study gluconeogenesis. Substrate cycling between glycerol and triose phosphates in liver.
Previs SF; Fernandez CA; Yang D; Soloviev MV; David F; Brunengraber H
J Biol Chem; 1995 Aug; 270(34):19806-15. PubMed ID: 7649990
[TBL] [Abstract][Full Text] [Related]
4. Gluconeogenesis and intrahepatic triose phosphate flux in response to fasting or substrate loads. Application of the mass isotopomer distribution analysis technique with testing of assumptions and potential problems.
Neese RA; Schwarz JM; Faix D; Turner S; Letscher A; Vu D; Hellerstein MK
J Biol Chem; 1995 Jun; 270(24):14452-66. PubMed ID: 7782307
[TBL] [Abstract][Full Text] [Related]
5. Limitations of the mass isotopomer distribution analysis of glucose to study gluconeogenesis. Heterogeneity of glucose labeling in incubated hepatocytes.
Previs SF; Hallowell PT; Neimanis KD; David F; Brunengraber H
J Biol Chem; 1998 Jul; 273(27):16853-9. PubMed ID: 9642245
[TBL] [Abstract][Full Text] [Related]
6. The effect of fasting and fructose and glucose infusion on gluconeogenesis and triose phosphate flux in rats in vivo.
Wolf G
Nutr Rev; 1995 Oct; 53(10):299-301. PubMed ID: 8584289
[TBL] [Abstract][Full Text] [Related]
7. Limitations in estimating gluconeogenesis and Cori cycling from mass isotopomer distributions using [U-13C6]glucose.
Landau BR; Wahren J; Ekberg K; Previs SF; Yang D; Brunengraber H
Am J Physiol; 1998 May; 274(5):E954-61. PubMed ID: 9612255
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the contribution of gluconeogenesis to glucose production in fasted human subjects using stable isotopes.
Landau BR
Proc Nutr Soc; 1999 Nov; 58(4):963-72. PubMed ID: 10817164
[TBL] [Abstract][Full Text] [Related]
9. Correction of 13C mass isotopomer distributions for natural stable isotope abundance.
Fernandez CA; Des Rosiers C; Previs SF; David F; Brunengraber H
J Mass Spectrom; 1996 Mar; 31(3):255-62. PubMed ID: 8799277
[TBL] [Abstract][Full Text] [Related]
10. Measuring gluconeogenesis with [2-13C]glycerol and mass isotopomer distribution analysis of glucose.
Peroni O; Large V; Beylot M
Am J Physiol; 1995 Sep; 269(3 Pt 1):E516-23. PubMed ID: 7573429
[TBL] [Abstract][Full Text] [Related]
11. 13C NMR measurements of human gluconeogenic fluxes after ingestion of [U-13C]propionate, phenylacetate, and acetaminophen.
Jones JG; Solomon MA; Sherry AD; Jeffrey FM; Malloy CR
Am J Physiol; 1998 Nov; 275(5):E843-52. PubMed ID: 9815005
[TBL] [Abstract][Full Text] [Related]
12. Hepatic UDP-glucose 13C isotopomers from [U-13C]glucose: a simple analysis by 13C NMR of urinary menthol glucuronide.
Mendes AC; Caldeira MM; Silva C; Burgess SC; Merritt ME; Gomes F; Barosa C; Delgado TC; Franco F; Monteiro P; Providencia L; Jones JG
Magn Reson Med; 2006 Nov; 56(5):1121-5. PubMed ID: 17036288
[TBL] [Abstract][Full Text] [Related]
13. Contributions of gluconeogenesis to glucose production in the fasted state.
Landau BR; Wahren J; Chandramouli V; Schumann WC; Ekberg K; Kalhan SC
J Clin Invest; 1996 Jul; 98(2):378-85. PubMed ID: 8755648
[TBL] [Abstract][Full Text] [Related]
14. Mass and positional isotopomer analysis of glucose metabolism in periportal and pericentral hepatocytes.
Cline GW; Shulman GI
J Biol Chem; 1995 Nov; 270(47):28062-7. PubMed ID: 7499292
[TBL] [Abstract][Full Text] [Related]
15. Glycerol's contribution to lactate production outside of a glucose intermediate in fasting humans.
Shah A; Wang Y; Su X; Wondisford FE
Metabolism; 2022 Jul; 132():155214. PubMed ID: 35562085
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of gluconeogenesis following alcohol in humans.
Siler SQ; Neese RA; Christiansen MP; Hellerstein MK
Am J Physiol; 1998 Nov; 275(5):E897-907. PubMed ID: 9815011
[TBL] [Abstract][Full Text] [Related]
17. Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state.
Landau BR; Wahren J; Chandramouli V; Schumann WC; Ekberg K; Kalhan SC
J Clin Invest; 1995 Jan; 95(1):172-8. PubMed ID: 7814612
[TBL] [Abstract][Full Text] [Related]
18. Gluconeogenesis and the Cori cycle in 12-, 20-, and 40-h-fasted humans.
Katz J; Tayek JA
Am J Physiol; 1998 Sep; 275(3):E537-42. PubMed ID: 9725823
[TBL] [Abstract][Full Text] [Related]
19. A critical evaluation of mass isotopomer distribution analysis of gluconeogenesis in vivo.
Previs SF; Cline GW; Shulman GI
Am J Physiol; 1999 Jul; 277(1):E154-60. PubMed ID: 10409139
[TBL] [Abstract][Full Text] [Related]
20. Quantification of hepatic transaldolase exchange activity and its effects on tracer measurements of indirect pathway flux in humans.
Jones JG; Garcia P; Barosa C; Delgado TC; Caldeira MM; Diogo L
Magn Reson Med; 2008 Feb; 59(2):423-9. PubMed ID: 18183605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
